Avience Biomedicals Ltd. IPO

Min Investment
₹ 1,24,800 / 600 shares
Price Range
₹196 - ₹ 208
Bidding Dates
18 Jun '26 - 22 Jun '26
Total Issue Value
30.24 Cr
Lot Size
600
Total Issue Size
30.24 Cr
Listing At
NSE SME

IPO Timeline

  • 18 Jun 2026
    Bidding Starts
  • 22 Jun 2026
    Bidding Ends
  • 23 Jun 2026
    Allotment Finalization
  • 25 Jun 2026
    Listing

About Avience Biomedicals Ltd.

Our Company was originally incorporated as Private Limited, under the Companies Act, 2013 (“Companies Act”) in the name and style of “Avience Biomedicals Private Limited” on December 23, 2019, under the provisions of the Companies Act, 2013 vide Certificate of ... Read more

Parent organisation
Founded
Avience Biomedicals Ltd.
2019

Avience Biomedicals Ltd. IPO Reservation

Investors Category Shares Offered
Anchor Investors 4,09,800 (28.19%)
Market Makers 82,200 (5.65%)
Non Institutional Investors 2,07,000 (14.24%)
Qualified Institutional Buyers (QIBs) 2,73,600 (18.82%)
Retail Individual Investors (RIIs) 4,81,200 (33.1%)

Avience Biomedicals Ltd. Financial Information

Year End Revenue PAT Reserves & Surplus
31 Mar 2025 29.54 Cr 5.14 Cr 16.49 Cr
31 Mar 2024 16.64 Cr 1.98 Cr 2.77 Cr
31 Mar 2023 10.93 Cr 70.78 Lakh 78.52 Lakh

Avience Biomedicals Ltd. Background

Major Events And Milestones
  • 2022
    Inauguration of Noida Factory
    A new production facility was established in Noida during the pandemic to support the country in its fight against COVID-19.
    Initiated E-Commerce Sales through Government e-Marketplace (GeM) OEM
    We were certified as an OEM in GeM and started our e-commerce operations as a result.
    New Manufacturing Licenses
    In FY 2022-23, we received approval for 10 additional production licenses
  • 2023
    Tenfold increase in turnover during FY 2021-22
    We achieved an approximately tenfold growth in turnover in FY 2021-22. In FY 2020-21, the turnover was ?113.30 lakhs, which increased to ?1,014.75 lakhs year over year.
    New Manufacturing Licenses
    We obtained four manufacturing licenses in FY 2021-22 which are as follows:
    1. Viral Transport Pack
    2. Pregnancy Card Pregnancy
    3. Strips Covid 19
    4. RT PCR Assay
    Allotment of land
    We secured an allotment of commercial land measuring 2,100 square meters within the Medical Device Park, located in the Yamuna Expressway Industrial Development Area, at a nominal lease rate. This strategically positioned land offers excellent connectivity to the airport and the expressway, enhancing logistical advantages for operations.
    First Export Consignment Dispatched
    The first export order has been successfully dispatched in FY 2023-24.
    Export Entry into the African Continent – Somalia
    The first export order to Somalia has been successfully completed and Company has entered the African continent.
    International Export Registration – Ethiopia
    We received approval from the Ethiopian Food and Drug Authority (EFDA) to export our products.
    Winning a bid in Andhra Pradesh for ₹82.05 lakhs
    We received a large government supply order after winning a bid in Andhra Pradesh for ?82.05/- lakhs.
    WHO Good Manufacturing Practice GMP Approval
    The WHO recognized our manufacturing process as a Good Manufacturing Practice (GMP) for producing quality products that meet international quality standards.
    MSME ZED Gold Certification
    As of November 13, 2024, there are only 1515 Zed Gold holders in India, and our company is one of them.
    New Manufacturing Licenses
    In FY 2023-24, we received approval for 31 new production licenses
  • 2024
    Laying of the foundation stone for the new factory
    Laying the foundation stone for the new large production facility at the Medical Device Park at Yamuna Expressway Industrial Development Area.
    Sickle Cell Approval
    We are one of the few manufacturers in India to receive validation for the sickle cell test from ICMR.
    Received the first license for the hematology analyzer
    We obtained our first license for manufacturing hematology equipment in FY 2024-25.
    Conversion of company
    Transitioned to a public company, marking a significant milestone in our growth and expansion.
    New Manufacturing Licenses
    In FY 2024-25, we received approval for 32 new production licenses
  • 2025
    New Manufacturing Licenses
    In FY 2025-26, we received approval for 11 new production licenses
  • 2026
    New Manufacturing Licenses
    In FY 2025-26, we received approval for 10 new production licenses
Avience Biomedicals Ltd. Object of Issues

1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the working capital requirement of our Company
3. General Corporate Purpose

Avience Biomedicals Ltd. IPO Listing Details
Listing Date
25 Jun 2026
ISIN
INE0V9I01017
Final Issue Price
₹ 208
Avience Biomedicals Ltd. Company Promoters

1. Mr. Dharam Deo Choudhary
2. Mr. Ram Nagina Choudhary
3. Mr. Janardan Pal
4. Mrs. Deepa Choudhary

Industry Overview

The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry. Major segments of Indian Pharmaceutical Industry include diagnostic kits, medical devices etc.

The healthcare and medical device sectors in India have grown significantly in the last decade. ... Read more

Avience Biomedicals Ltd. Contact Details
Address: C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi Delhi - 110058
Phone no:18001204636
18001204636
|
Avience Biomedicals Ltd. IPO Registrar
Skyline Financial Services Pvt. Ltd.
D-153 A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi Delhi - 110020
40450193 - 97
Avience Biomedicals Ltd. IPO Lead Manager(s)
Fintellectual Corporate Advisors Pvt. Ltd.
B-20, Second Floor, Sector-1, Noida Uttar Pradesh - 201301
4266080

FAQs

When does Avience Biomedicals Ltd. IPO opens and closes?

Avience Biomedicals Ltd. IPO opens from 18th June to 22nd June 2026.

What is the size of Avience Biomedicals Ltd. IPO?

The size of the Avience Biomedicals Ltd. IPO is ₹30.24 Cr.

What is the price range of Avience Biomedicals Ltd. IPO?

The price range of Avience Biomedicals Ltd. IPO is at ₹196 to ₹208 per share.

What is the minimum investment and lot size required for the Avience Biomedicals Ltd. IPO?

The minimum investment required is ₹1,24,800 and minimum lot size is 600 shares.

When is Avience Biomedicals Ltd. IPO listing date?

The Avience Biomedicals Ltd. IPO will be listed on 25th June 2026.

What is the objective of Avience Biomedicals Ltd. IPO?

1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the working capital requirement of our Company
3. General Corporate Purpose

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
X